The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance
policy guidance
1 January 2016
| Policy brief
Overview
This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB.
WHO Team
Global Programme on Tuberculosis and Lung Health (GTB),
Guidelines Review Committee
Editors
World Health Organization
Number of pages
52
Reference numbers
ISBN: 978-92-4-151056-1
WHO Reference Number: WHO/HTM/TB/2016.07